Home › Pagkabigo ng Puso › Florida › Tampa
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Tampa, FL
Isang pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tampa. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Nagre-recruitPhase 3
- University of South Florida, Tampa
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Nagre-recruitPhase 3
- University of South Florida, Tampa
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Nagre-recruit
- Tampa General Hospital, Tampa
Left vs Left Randomized Clinical Trial
Nagre-recruit
- University of South Florida, Tampa
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Nagre-recruit
- Tampa General Hospital, Tampa
- BayCare Health Systems, Tampa
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Nagre-recruitObservasyonal na pag-aaral
- Tampa, Tampa
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Nagre-recruitPhase 3
- USF Health South Tampa Center for Advanced Healthcare, Tampa
- Saint Josephs Hospitals, Tampa
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Nagre-recruit
- AdventHealth Tampa, Tampa
CCM OPEN HF Registry
Nagre-recruitObservasyonal na pag-aaral
- AdventHealth Tampa, Tampa
NORM-HF Pivotal Study
Nagre-recruit
- Tampa General Hospital, Tampa
- Baycare Health System, Tampa
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Nagre-recruitPhase 3
- Research Site, Tampa
Alleviant ALLAY-HFrEF Study
Nagre-recruit
- Tampa General Hospital, Tampa
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Nagre-recruitPhase 3
- Research Site, Tampa
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Nagre-recruit
- University of South Florida, Tampa
- BayCare Medical/St. Joseph's Hospital, Tampa
- AdventHealth Tampa, Tampa
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- St Joseph's Hospital Foundation, Tampa
- Tampa Cardiovascular Interventions and Research, Tampa
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Nagre-recruit
- Tampa General Hospital, Tampa
Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device
Nagre-recruitObservasyonal na pag-aaral
- USF Office of Clinical Research, Tampa
- USF, Tampa
His-Bundle Corrective Pacing in Heart Failure
Nagre-recruit
- University of South Florida, Tampa
Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod
- New York City, NY51 pag-aaral
- Boston, MA46 pag-aaral
- Dallas, TX42 pag-aaral
- Houston, TX35 pag-aaral
- Cleveland, OH31 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- Chicago, IL28 pag-aaral
- Durham, NC25 pag-aaral
- Kansas City, MO25 pag-aaral
- St. Louis, MO24 pag-aaral
- Indianapolis, IN24 pag-aaral
Iba pang pag-aaral sa Tampa
- Non-Small Cell Lung Cancer53 pag-aaral
- Kanser sa Suso40 pag-aaral
- Kanser (lahat ng uri)38 pag-aaral
- Colorectal Cancer36 pag-aaral
- Kanser sa Baga31 pag-aaral
- Metastatic Cancer30 pag-aaral
- Acute Myeloid Leukemia30 pag-aaral
- Kanser sa Pancreas26 pag-aaral
- Melanoma21 pag-aaral
- Kanser sa Ovary20 pag-aaral
- Sakit ni Alzheimer20 pag-aaral
- Myelodysplastic Syndromes20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.